Show simple item record

dc.contributor.authorMarsdal, Kjersti Engen
dc.contributor.authorSørbye, Ingvil Krarup
dc.contributor.authorBernitz, Stine
dc.contributor.authorSve, Ranveig Elise Tulluan
dc.contributor.authorAsk, Kristine
dc.contributor.authorLukasse, Mirjam
dc.date.accessioned2025-01-29T11:56:22Z
dc.date.available2025-01-29T11:56:22Z
dc.date.created2024-04-11T14:41:28Z
dc.date.issued2024
dc.identifier.citationActa Obstetricia et Gynecologica Scandinavica. 2024, 103 (6), 1101-1111.en_US
dc.identifier.issn0001-6349
dc.identifier.urihttps://hdl.handle.net/11250/3175095
dc.description.abstractIntroduction: Labor induction rates have increased over the last decades, and in many high-income countries, more than one in four labors are induced. Outpatient man- agement of labor induction has been suggested in low-risk pregnancies to improve women's birth experiences while also promoting a more efficient use of healthcare resources. The primary aim of this paper was to assess the proportion of women in a historical cohort that would have been eligible for outpatient labor induction with oral misoprostol. Second, we wanted to report safety outcomes and assess efficacy out- comes for mothers and infants in pregnancies that met the criteria for outpatient care. Material and methods: Criteria for outpatient labor induction with oral misoprostol were applied to a historical cohort of women with induction of labor at two Norwegian tertiary hospitals in the period January 1, through July 31, 2021. The criteria included low-risk women with an unscarred uterus expecting a healthy, singleton baby in ce- phalic position at term. The primary outcome was the proportion of women eligible for outpatient labor induction. Secondary outcomes included reasons for ineligibility and, for eligible women, safety and efficacy outcomes. Results: Overall, 29.7% of the 1320 women who underwent labor induction in a sin- gleton term pregnancy met the criteria for outpatient labor induction. We identified two serious adverse events that potentially could have occurred outside the hospital if the women had received outpatient care. The mean duration from initiation of labor induction to administration of the last misoprostol was 22.4 h. One in 14 multiparous women gave birth within 3 h after the last misoprostol dose. Conclusions: In this historical cohort, three in ten women met the criteria for outpa- tient management of labor induction with oral misoprostol. Serious adverse events were rare. The average time span from the initiation of labor induction to the last misoprostol was nearly 24 h. This suggests a potential for low-risk women with an induced labor to spend a substantial period of time at home before labor onset.en_US
dc.language.isoengen_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleOutpatient labor induction—Exploring future potential by assessing eligibility in a historical cohorten_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1111/aogs.14799
dc.identifier.cristin2261117
dc.source.journalActa Obstetricia et Gynecologica Scandinavicaen_US
dc.source.volume103en_US
dc.source.issue6en_US
dc.source.pagenumber1101-1111en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse-Ikkekommersiell 4.0 Internasjonal